Skip to main content
Non-canonical functions of the RB protein in cancer
Nature Reviews Cancer
  • Frederick A. Dick, Western University
  • David W. Goodrich, Roswell Park Cancer Institute
  • Julien Sage, Stanford University
  • Nicholas J. Dyson, Harvard Medical School
Document Type
Publication Date
URL with Digital Object Identifier

The canonical model of RB-mediated tumour suppression developed over the past 30 years is based on the regulation of E2F transcription factors to restrict cell cycle progression. Several additional functions have been proposed for RB, on the basis of which a non-canonical RB pathway can be described. Mechanistically, the non-canonical RB pathway promotes histone modification and regulates chromosome structure in a manner distinct from cell cycle regulation. These functions have implications for chemotherapy response and resistance to targeted anticancer agents. This Opinion offers a framework to guide future studies of RB in basic and clinical research.

Citation Information
Frederick A. Dick, David W. Goodrich, Julien Sage and Nicholas J. Dyson. "Non-canonical functions of the RB protein in cancer" Nature Reviews Cancer Vol. 18 Iss. 7 (2018) p. 442 - 451
Available at: